美波利祖马布
医学
支气管扩张
恶化
哮喘
四分位间距
维持疗法
内科学
人口
嗜酸性
胃肠病学
嗜酸性粒细胞
肺
病理
化疗
环境卫生
作者
Sarah Bendien,Johannes A. Kroes,Lotte H.G. van Hal,Gert‐Jan Braunstahl,M.E.A.C. Broeders,Karen T.M. Oud,Kornelis W. Patberg,Frank W.J.M. Smeenk,Ilonka H.P.A.A. van Veen,Els J.M. Weersink,Karin B. Fieten,Simone Hashimoto,Anneke van Veen,Jacob K. Sont,Astrid van Huisstede,Marjo J.T. van de Ven,Bas Langeveld,Anke H. Maitland‐van der Zee,Anneke Ten Brinke
标识
DOI：10.1016/j.jaip.2023.05.041
摘要
This real-world study shows that anti-IL-5/5Ra therapy reduces exacerbation frequency and daily maintenance as well as the cumulative OCS dose in patients with severe eosinophilic asthma and comorbid bronchiectasis. Although it is an exclusion criterion in phase 3 trials, comorbid bronchiectasis should not preclude anti-IL-5/5Ra therapy in patients with severe eosinophilic asthma.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
干净的琦
陈蒙医生
zhangwenkang
99
东方元语
贪玩的秋柔
YifanWang
初景
迅速静柏
辛勤冬天
AllRightReserved
华仔
迷你的听荷
无极微光
zxx
OK
木子也是李
可爱的函函
慕青
皖公网安备34019202002308
